Lower Antibodies Against Omicron Induced by Two-Dose Vaccines
Written by RadioVuna on December 14, 2021
Two-dose COVID-19 Scientists in the United Kingdom discovered that vaccination regimens did not produce enough neutralizing antibodies against the Omicron coronavirus variant, suggesting that higher infections in people who have already been sick or vaccinated may be a possibility.
In a study that has not yet been peer-reviewed, researchers from the University of Oxford published results on Monday from blood samples taken from participants who received doses from either AstraZeneca-Oxford (AZN.L) or Pfizer-BioNTech (PFE.N), (22UAy.DE) in a major study looking into vaccine mixing. The study was funded by the pharmaceutical companies AstraZeneca-Oxford (AZN.L) and Pfizer-Bio
Just after British Prime Minister Boris Johnson cautioned that two doses would not be enough to keep Omicron at bay, after data from the United Kingdom’s health agency last week showed boosters dramatically increase protection against the strain.
According to the findings of the Oxford research, there is currently no indication that having a lower degree of disease antibodies against Omicron increases the risk of serious sickness, hospitalization, or death in people who have received two doses of licensed vaccinations.
“These statistics are essential, but they only represent a portion of the whole picture. However, they simply look at neutralizing antibodies just after second dosage, and they do not tell us anything about cellular immunity, which will be studied as well “Matthew Snape, an Oxford professor and founder of the work, shared his thoughts.
Reader's opinions
Continue reading
